Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis-Reference-Cited by-同舟云学术

Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis

Published:2019-12-16 Issue:4 Volume:86 Page:698-710
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Weatherburn Christopher J.¹,Guthrie Bruce²,Dreischulte Tobias³,Morales Daniel R.⁴^ORCID

Affiliation:

1. General Practitioner, Division of Population Health and GenomicsUniversity of Dundee UK

2. General Practice, Centre for Population Health Sciences, Usher InstituteUniversity of Edinburgh UK

3. Clinical Health Services Research, Institute of General Practice and Family MedicineUniversity Hospital of Ludwig‐Maximilians‐University Munich Germany

4. Discovery Fellow and General Practitioner, Division of Population Health and GenomicsUniversity of Dundee UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14104

Reference63 articles.

1. Incidence of Adverse Drug Reactions in Hospitalized Patients

2. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

3. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010

4. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

5. European Medicines Agency. PRAC recommends new measures to avoid valproate exposure during pregnancy. 09/02/2018. Available at:https://www.ema.europa.eu/en/news/prac‐recommends‐new‐measures‐avoid‐valproate‐exposure‐pregnancy.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do responses to news matter? Evidence from interventional cardiology;Journal of Health Economics;2024-03

2. Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023;Drug Safety;2023-11-02

3. Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends;Drug Safety;2023-03-28

4. Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review;Research in Social and Administrative Pharmacy;2023-01

5. Sustainable risk management practice in the organization: a Malaysian case study;Environmental Science and Pollution Research;2022-11-08